Related Experiment Video
Updated: Jun 25, 2025
12:55
Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
Published on: February 16, 2015
21.4K
Revisiting Temozolomide's role in solid tumors: Old is gold?
Dimitrios Matthaios1, Ioanna Balgkouranidou2, Konstantinos Neanidis3
1Department of Oncology, General Hospital of Rhodes, Rhodes, Greece.
Journal of Cancer
|May 31, 2024
Summary
Temozolomide, an established chemotherapy, is showing expanded potential beyond brain tumors and melanoma. New research highlights its efficacy in other solid tumors, offering a new treatment option for aggressive cancers.
Area of Science:
- Oncology
- Pharmacology
- Immunotherapy
Background:
- Temozolomide, an imidazotetrazine, is a well-established chemotherapeutic agent.
- Its primary indications have historically been high-grade malignant glioma and metastatic melanoma.
- Recent advancements are broadening its therapeutic applications.
Purpose of the Study:
- To review the expanding indications for temozolomide in oncology.
- To highlight factors driving its potential use in additional solid tumors.
- To underscore its role as a versatile tool in treating advanced neoplasms.
Main Methods:
- Review of recent oncological and pharmacological literature.
- Analysis of temozolomide's pharmacodynamic profile and blood-brain barrier penetration.
- Evaluation of MGMT methylation status, resistance mechanisms, and immunomodulatory effects.
Main Results:
- Temozolomide exhibits an optimal pharmacodynamic profile and excellent blood-brain barrier penetration.
- MGMT methylation in tumors enhances temozolomide efficacy.
- New agents are identified to overcome resistance, and temozolomide shows promise in converting 'immune cold' tumors to 'hot' ones.
Conclusions:
- The unique properties of temozolomide support its expanded use in various solid tumors.
- Its ability to enhance efficacy through MGMT methylation and modulate the tumor immune microenvironment is significant.
- Temozolomide represents a valuable addition to the oncologist's armamentarium for advanced and aggressive cancers.
Related Concept Videos
01:27Tumor Immunotherapy
514
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
514
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
02:17The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K